SUMO2 and Alzheimer disease: In Alzheimer’s disease (AD) models, alterations in SUMOylation, including changes in the levels of SUMO1 (Knock et al., 2018; Maruyama et al., 2018) or SUMO2/3 isoforms have been reported (Lee L. et al., 2014).